SecBot SecBot
144 ·Filed Oct 26, 2026

DGX

QUEST DIAGNOSTICS INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed21d 12h ago SEC0001959173-26-007482
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine director sale of shares acquired through vesting. No material signal for the stock. Monitor for any larger insider sales or changes in insider filing patterns ahead of the next earnings report.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$242.95
T+0 close · Oct 26, 2026 · via day close
Latest settled
+3.65%
T+5 · $251.82 · next T+20 in 6d
Vs SPY
+4.91%
α at T+5
Latest observation
+6.46%
T+14 · FF3 residual α
  1. T+0 · Oct 26 $242.95entry
  2. T+1 · 21d ago −0.16%α −0.72% · $242.56
  3. T+5 · 15d ago +3.65%α +4.91% · $251.82
  4. T+15 · todayOpen
  5. T+20 · in 6d Pending
  6. T+60 · in 2mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Gary M. Pfeiffer filed a Form 144 notice of intent to sell 1,203 shares of Quest Diagnostics common stock, valued at approximately $292,329 based on the filing. The shares were acquired through restricted stock vesting on May 15, 2026, and the sale is planned for the NYSE. This is a small, routine sale by a director relative to the company's $26.9B market cap.

Key Facts

  • Director Gary M. Pfeiffer filed Form 144 to sell 1,203 shares of Quest Diagnostics common stock.
  • The approximate market value of the proposed sale is $292,329.
  • Shares were acquired via restricted stock vesting on May 15, 2026, as compensation.
  • The sale is planned for execution on the NYSE on October 26, 2026.
  • The proposed sale represents a tiny fraction of the company's $26.9B market cap.

Financial Impact

Proposed sale of 1,203 shares valued at ~$292,329, negligible relative to $26.9B market cap.

dilution

Risk Factors

  • Form 144 is an intent to sell; the sale may not be executed.
  • No other insider selling context provided to assess pattern.

Market Snapshot

Exchange
NYSE
Sector
Services-Medical Laboratories
Analyst Consensus
57% bullish (23 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-007482
Document: 0001959173-26-007482-index.html0001959173-26-007482
Document: 0001959173-26-007482.txt0001959173-26-007482

Track record

24 reports on DGX

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +7.06% at T+5 after the Sep 9, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 2/10 Entry price pending
  2. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $259.60 Now $262.21 +1.01% settles Feb 11
  3. Nov 10, 20266d ago Press Release Neutral 2/10 Entry $258.69 Now $262.21 +1.36% settles Feb 9
  4. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $258.44 Now $262.21 +1.46% settles Feb 8
  5. Nov 9, 20267d ago Press Release Neutral 2/10 Entry $259.67 Now $262.21 +0.98% settles Feb 5
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $259.67 Now $262.21 +0.98% settles Feb 5
  7. Nov 5, 202611d ago 3 Neutral 2/10 Entry $255.63 Now $262.21 +2.57% settles Feb 4
  8. Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $247.06 Now $262.21 +6.13% settles Feb 1
  9. Nov 3, 202613d ago 144 Neutral 3/10 Entry $247.06 Now $262.21 +6.13% settles Feb 1
  10. Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $245.62 Now $262.21 +6.75% settles Jan 26
Showing 10 of 24

US Market Status

Market Closed · Opens Wed (11h 45m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 26, 2026